Vanguard Group Inc. Decreases Stake in Chemours

Investment firm reduces holdings in specialty chemicals company by 1.3% in Q3

Mar. 3, 2026 at 12:15am

Got story updates? Submit your updates here. ›

Vanguard Group Inc. decreased its position in The Chemours Company (NYSE:CC) by 1.3% in the 3rd quarter, according to a recent SEC filing. The firm owned 17,430,090 shares of the specialty chemicals company's stock, worth approximately $276,093,000, after selling 233,890 shares during the period.

Why it matters

As one of Chemours' largest institutional investors, Vanguard's decision to slightly reduce its stake in the company could signal a shift in sentiment or outlook for the specialty chemicals firm among major investors.

The details

Vanguard Group, a leading global investment management company, decreased its holdings in Chemours by 1.3% in the third quarter of 2025. The firm now owns approximately 17.43 million shares, or 11.64% of the company's outstanding stock, valued at $276.09 million.

  • Vanguard reduced its Chemours holdings in the 3rd quarter of 2025.

The players

Vanguard Group Inc.

A global investment management company that is one of the largest institutional investors in Chemours.

The Chemours Company

A specialty chemicals company headquartered in Wilmington, Delaware.

Got photos? Submit your photos here. ›

The takeaway

Vanguard's modest reduction in its Chemours stake, while relatively small, could signal a shift in sentiment among major investors towards the specialty chemicals firm as it navigates market conditions and competitive pressures.